Keyphrases
Malignant Pleural Mesothelioma
100%
Tailored Treatment
100%
DNA Repair Genes
100%
Germline Variants
100%
DNA Repair
44%
BRCA1-associated Protein 1 (BAP1)
22%
Ataxia Telangiectasia mutated
22%
Three-dimensional (3D)
11%
In Vitro Study
11%
Mesothelioma Cells
11%
Asbestos Exposure
11%
Tumor-associated
11%
Next-generation Sequencing
11%
Cancer Genes
11%
Unselected Patients
11%
Breast Cancer Susceptibility Gene 1 (BRCA1)
11%
Inherited Predisposition
11%
SLX4
11%
Apoptosis Induction
11%
Master Regulator
11%
Germline DNA
11%
Genome Sequence Analysis
11%
Synthetic Lethality
11%
Germline Pathogenic Variant
11%
Tazemetostat
11%
Custom Panel
11%
Enhancer of Zeste Homolog 2 Inhibitors
11%
Predisposing Genes
11%
CHEK2
11%
New Pathogenic Variant
11%
BRIP1
11%
Flcn
11%
Biochemistry, Genetics and Molecular Biology
Germline
100%
Germ Cell
100%
DNA Repair
100%
Next Generation Sequencing
28%
BAP1
28%
Ataxia Telangiectasia Mutated
28%
In Vitro Study
14%
Prevalence
14%
BRCA1
14%
Tumor Spheroid
14%
Transcription Factor EZH2
14%
CHEK2
14%
BRIP1
14%
Programmed Cell Death
14%
Medicine and Dentistry
Pleura Mesothelioma
100%
DNA Repair
100%
Germ Cell
100%
Next Generation Sequencing
22%
Ataxia Telangiectasia
22%
Neoplasm
11%
In Vitro
11%
Malignant Neoplasm
11%
Programmed Cell Death
11%
Prevalence
11%
Asbestos Exposure
11%
Disease Predisposition
11%
BRCA1
11%
Tumor Spheroid
11%
Lethality
11%
Tazemetostat
11%
Transcription Factor EZH2
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pleura Mesothelioma
100%
Ataxia Telangiectasia
22%
Malignant Neoplasm
11%
Neoplasm
11%
Prevalence
11%
Disease Predisposition
11%
Lethality
11%
Transcription Factor EZH2
11%
Tazemetostat
11%